Subscribe to our Newsletters !!

    Kumar Jeetendra

    Researchers grow new serological assay for discovery of SARS-CoV-2 antibodies

    Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus which causes COVID-19. Rebecca DuBois, associate professor of biomolecular engineering at UC Santa Cruz, said the new method her staff developed is as accurate as the most dependable antibody tests now available, but is less

    Researchers grow first biohybrid fake retina with silk fibroin and retinal cells

    An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina constructed with silk fibroin and retinal cells. The biohybrid retina is a cell therapy for the reconstruction of the damaged retina by

    HiMedia’s Molecular Biology Division gets ICMR nod along with CE/IVD approvals for their COVID range of products

    HiGenoMB®, the Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the leading Indian BioSciences manufacturer proudly announces that it has received the prestigious ICMR and CE/IVD approval for its COVID Range of Products. 1.Hi-PCR® Coronavirus (COVID-19) Multiplex Probe PCR Kits (MBPCR243) 2.HiPurA® Viral RNA Purification Kit (MB615) 3.HiPurA® Viral RNA Purification Kit – Magnetic Bead

    Roche partnered with Moderna to Include Antibody Test in Covid-19 Vaccine Trials

    Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 Compounds and help to establish a correlation between vaccine-induced protection and degrees of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers

    Custom Design and Manufacture of Specialist Microplates

    Porvair Sciences provides a complete design and manufacture service to help customers develop new and innovative custom microplates for specialist applications. Porvair Sciences is widely recognised as a leader in the field of moulding ultra-pure plastic materials such as polystyrene, polypropylene and polycarbonate. With decades of experience and expertise in ultrasonic welding, surface treatment techniques,

    Lonza’s MODA-EM™ Paperless Solution to be Implemented at the UK’s New Vaccines Manufacturing and Innovation Centre

    Basel, Switzerland and Harwell, UK, 07 December 2020 – Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability, announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility. VMIC plans to implement

    First enzyme driven biocatalytic creation of nucleic acid structure blocks

    Researchers in TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of lipoic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics. Because of this COVID 19 pandemic and the related intensive search for therapeutics and vaccines, the chemical substance class of nucleosides is undergoing an enormous increase in

    WHO says specialists examining new COVID-19 variant in England

    Myth 1: Mental illnesses are rare | On October 7, the World Health Organization said “close to one billion people globally have a mental disorder”. (Image: Reuters) The World Health Organization is aware of a new variant of COVID-19 that has emerged in Britain, but there is no evidence the strain behaves differently to existing

    ENPICOM and MiLaboratories join forces to power better Repertoire Sequencing data management and analysis workflows

    ENPICOM BV, an innovative bioinformatics software engineering company, and MiLaboratories LLC, a technology leader in profiling the mammalian adaptive immune system, announced a strategic partnership to enable efficient MiXCR integration into ENPICOM’s cloud-based IGX Platform. Combining the best of both software solutions within a single platform MiXCR is a universal, state-of-the-art software solution for annotation